Risk factors for breast cancer are often confusing and contradictory. Discrepancies are likely due to different subtypes having divergent risk factors. An important distinction between breast cancer subtypes is hormone-receptor status. Compared to women diagnosed with estrogen receptor positive (ER+) breast cancer, those with estrogen receptor negative (ER−) tumors are usually diagnosed at a younger age and have a higher mortality [1]. Few studies have attempted to explain ‘why’ breast cancer subtypes have different risk factors.
Details
- Is Estrogen Receptor Negative Breast Cancer Risk Associated With a Fast Life History Strategy?
- Hidaka, Brandon H. (Author)
- Boddy, Amy (Author)
- College of Liberal Arts and Sciences (Contributor)
- Digital object identifier: 10.1093/emph/eov034
- Identifier TypeInternational standard serial numberIdentifier Value2050-6201
- The final version of this article, as published in Evolution, Medicine, and Public Health, can be viewed online at: https://academic.oup.com/emph/article-lookup/doi/10.1093/emph/eov034, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Hidaka, B. H., & Boddy, A. M. (2016). Is estrogen receptor negative breast cancer risk associated with a fast life history strategy? Evolution, Medicine, and Public Health, 2016(1), 17-20. doi:10.1093/emph/eov034